Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/214024
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rades, Dirk | - |
dc.contributor.author | Lomidze, Darejan | - |
dc.contributor.author | Jankarashvili, Natalia | - |
dc.contributor.author | Lopez Campos, Fernando | - |
dc.contributor.author | Navarro-martin, Arturo | - |
dc.contributor.author | Segedin, Barbara | - |
dc.contributor.author | Groselj, Blaz | - |
dc.contributor.author | Staackmann, Christian | - |
dc.contributor.author | Kristiansen, Charlotte | - |
dc.contributor.author | Dennis, Kristopher | - |
dc.contributor.author | Schild, Steven E. | - |
dc.contributor.author | Cacicedo, Jon | - |
dc.date.accessioned | 2024-07-01T09:09:06Z | - |
dc.date.available | 2024-07-01T09:09:06Z | - |
dc.date.issued | 2024-03-14 | - |
dc.identifier.uri | http://hdl.handle.net/2445/214024 | - |
dc.description.abstract | Simple Summary Patients with MESCC and favorable survival prognoses assigned to radiotherapy alone may benefit from increased doses. In a multi-center phase 2 trial, patients receiving 15 x 2.633 Gy or 18 x 2.333 Gy were evaluated and subsequently compared to a historical control group receiving 10 x 3.0 Gy. The phase 2 cohort, including 50 (of 62 planned) evaluable patients, showed promising results regarding 12-month local progression-free survival (LPFS), 12-month overall survival (OS), improvement of motor and sensory functions, post-radiotherapy ambulatory status, and relief of pain and distress. Radiotherapy with 15 x 2.633 Gy or 18 x 2.333 Gy was well tolerated and appeared more effective than 10 x 3.0 Gy with respect to LPFS and improvement of motor function.Abstract Patients with metastatic epidural spinal cord compression (MESCC) and favorable survival prognoses may benefit from radiation doses exceeding 10 x 3.0 Gy. In a multi-center phase 2 trial, patients receiving 15 x 2.633 Gy (41.6 Gy10) or 18 x 2.333 Gy (43.2 Gy10) were evaluated for local progression-free survival (LPFS), motor/sensory functions, ambulatory status, pain, distress, toxicity, and overall survival (OS). They were compared (propensity score-adjusted Cox regression) to a historical control group (n = 266) receiving 10 x 3.0 Gy (32.5 Gy10). In the phase 2 cohort, 50 (of 62 planned) patients were evaluated for LPFS. Twelve-month rates of LPFS and OS were 96.8% and 69.9%, respectively. Motor and sensory functions improved in 56% and 57.1% of patients, and 94.0% were ambulatory following radiotherapy. Pain and distress decreased in 84.4% and 78.0% of patients. Ten and two patients experienced grade 2 and 3 toxicities, respectively. Phase 2 patients showed significantly better LPFS than the control group (p = 0.039) and a trend for improved motor function (p = 0.057). Ambulatory and OS rates were not significantly different. Radiotherapy with 15 x 2.633 Gy or 18 x 2.333 Gy was well tolerated and appeared superior to 10 x 3.0 Gy. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI AG | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/cancers16061149 | - |
dc.relation.ispartof | Cancers, 2024, vol. 16, issue. 6, p. 1149 | - |
dc.relation.uri | https://doi.org/10.3390/cancers16061149 | - |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.title | Radiotherapy for Metastatic Epidural Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial | - |
dc.type | info:eu-repo/semantics/article | - |
dc.date.updated | 2024-06-13T10:18:03Z | - |
dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
cancers-16-01149-v2.pdf | 1.34 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.